Growth Metrics

AbCellera Biologics (ABCL) Short-Term Debt repayments (2020)

AbCellera Biologics (ABCL) has disclosed Short-Term Debt repayments for 1 consecutive years, with $387000.0 as the latest value for Q1 2020.